84 related articles for article (PubMed ID: 6139947)
21. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
22. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone.
Huh N; Utakoji T
Gan; 1981 Feb; 72(1):178-9. PubMed ID: 6268479
[No Abstract] [Full Text] [Related]
23. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus.
Jayaram S; Thyagarajan SP
Indian J Pathol Microbiol; 1996 Jul; 39(3):211-5. PubMed ID: 8972151
[TBL] [Abstract][Full Text] [Related]
25. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
Leveille-Webster CR; Arias IA
Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
[TBL] [Abstract][Full Text] [Related]
26. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B surface antigen produced by a human hepatoma cell line.
MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
[TBL] [Abstract][Full Text] [Related]
28. [Solid tumours of human primary hepatocellular carcinoma cell-lines in hypothymic mice: a model for biochemical and therapeutic studies (author's transl)].
Hahn EG; Gauss-Müller V; Hornberger M; Kalbfleisch H; Deinhardt F
Z Gastroenterol; 1982 Mar; 20(3):168-73. PubMed ID: 6177113
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
30. Effect of a xanthine analog on human hepatocellular carcinoma cells (Alexander) in culture and in xenografts in SCID mice.
Marucci L; Varticovski L; Arias IM
Hepatology; 1997 Nov; 26(5):1195-202. PubMed ID: 9362362
[TBL] [Abstract][Full Text] [Related]
31. Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.
Wills PJ; Asha VV
J Ethnopharmacol; 2009 Mar; 122(2):294-303. PubMed ID: 19168119
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
33. [Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells].
Bagnarelli P; Festa A; Testa I; Manzin A; Clementi M
Boll Soc Ital Biol Sper; 1985 Oct; 61(10):1513-20. PubMed ID: 3006729
[No Abstract] [Full Text] [Related]
34. Studies by immune electron microscopy of hepatitis B surface antigen in PLC/PRF/5 cells.
Shibayama T; Watanabe T; Kojima H; Yoshikawa A; Watanabe S; Kamimura T; Suzuki S; Ichida F
J Med Virol; 1984; 13(3):205-14. PubMed ID: 6327897
[TBL] [Abstract][Full Text] [Related]
35. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
Volc-Platzer B; Hanak H; Weiss W; Denk H
Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
[TBL] [Abstract][Full Text] [Related]
37. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
38. Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report.
Clementi M; Bagnarelli P; Pauri P; Brugia M
Arch Virol; 1983; 78(1-2):109-13. PubMed ID: 6316871
[TBL] [Abstract][Full Text] [Related]
39. Modulation of production of hepatitis B surface antigen by a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P; Calegari L
J Med Virol; 1984; 13(2):117-23. PubMed ID: 6198456
[TBL] [Abstract][Full Text] [Related]
40. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
